TGFB1 and neoplasm: Similar observations were made in a MDA-MB-231 model of bone metastasis, where the reduced tumor burden in the bones after TGF-β inhibition was much more pronounced when TGF-β blockade was administered directly after tumor inoculation, compared with administration when metastases in the bones were already established (36).